Related Experiment Videos
Failed prostaglandin abortion associated with placenta accreta. A case report
1Department of Obstetrics and Gynecology, University of Tennessee, Chattanooga Unit.
The Journal of Reproductive Medicine
|November 1, 1994
Summary
Prostaglandin E2 vaginal suppositories are effective for second-trimester abortion. This case report details a rare instance of abortion failure linked to placenta accreta, highlighting the need to investigate underlying causes.
Area of Science:
- Reproductive Medicine
- Obstetrics & Gynecology
- Maternal-Fetal Medicine
Background:
- Prostaglandin E2 vaginal suppositories are a standard method for second-trimester pregnancy termination.
- Effective management of failed prostaglandin abortions requires identifying the specific cause of failure.
Observation:
- This case report presents a unique instance of prostaglandin-induced abortion failure.
- The failure was associated with the presence of placenta accreta, a condition where the placenta abnormally attaches to the uterine wall.
Findings:
- This is the first documented case of failed prostaglandin abortion attributed to placenta accreta.
- Placenta accreta can significantly complicate or prevent successful pregnancy termination using medical methods.
Implications:
- Clinicians should consider placenta accreta in the differential diagnosis for failed prostaglandin abortions.
- This finding may necessitate alternative or more aggressive management strategies for pregnancy termination in patients with suspected placenta accreta.